Hetero Competitors and Similar CompaniesClear all

Hetero's competitors and similar companies include Astellas Pharma, WuXi AppTec, Qilu Pharmaceutical and Intas Pharmaceuticals.
Hetero
Hetero
Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs.
Astellas Pharma
Astellas Pharma
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
WuXi AppTec
WuXi AppTec
WuXi AppTec (药明康德, formerly known as WuXi PharmaTech) is a company providing research, development, and manufacturing services to discover and manufacture small molecule drugs and cell and gene therapies.
Qilu Pharmaceutical
Qilu Pharmaceutical
Qilu Pharmaceutical (齐鲁制药) is a company that develops, manufactures, and markets generic drugs and active pharmaceutical ingredients (APIs).
Intas Pharmaceuticals
Intas Pharmaceuticals
Intas is one of the leading global pharmaceutical formulation development, manufacturing, and marketing companies.
Founding Date
Founding Date
1993
Founding Date
1923
Founding Date
2000
Founding Date
1958
Founding Date
1996
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Hyderabad, IN HQ
Norwest, AU
Sao Paulo, BR
Beijing, CN
Nanjing Shi, CN
Nanjing Shi, CN
Bogotá, CO
see more
Locations
Tokyo, JP HQ
Macquarie Park, AU
Wien, AT
Vilvoorde, BE
São Paulo, BR
Markham, CA
Beijing, CN
see more
Locations
Shanghai, CN HQ
Beijing, CN
Changzhou, CN
Chengdu, CN
Guangzhou, CN
Nantong, CN
Shanghai, CN
see more
Locations
Jinan Shi, CN HQ
Boston, US
Locations
Ahmedabad, IN HQ
Durham, US
Employees
Employees
7,0042% increase
Employees
14,754
Employees
39,414
Employees
39,0008% increase
Employees
17,4211% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
20.8 b
Valuation ($)
20.7 b
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥1.9t (FY, 2025)
Revenue (est.)
¥37.6b (FY, 2024)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
¥150.1b (FY, 2025)
Cost of goods
¥23b (FY, 2024)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
¥1.8t (FY, 2025)
Gross profit
¥16b (FY, 2024)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
¥50.7b (FY, 2025)
Net income
¥9.6b (FY, 2024)
Net income
N/A
Net income
N/A

Operating

Scientists and Researchers
Scientists and Researchers
1 k (Jan, 2021)
Scientists and Researchers
N/A
Scientists and Researchers
38 k (H1, 2023)
Scientists and Researchers
N/A
Scientists and Researchers
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 902.6m
Total funding raised
N/A
Total funding raised
$ 295.2m
For sources of this data, please see the company profile

View Company Profiles

Astellas Pharma
HQ
Tokyo, JP
Employees
14,754

Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.

View company
WuXi AppTec
HQ
Shanghai, CN
Employees
39,414

WuXi AppTec (药明康德, formerly known as WuXi PharmaTech) is a company providing research, development, and manufacturing services to discover and manufacture small molecule drugs and cell and gene therapies.

View company
Qilu Pharmaceutical
HQ
Jinan Shi, CN
Employees
39,000↑ 8% increase

Qilu Pharmaceutical (齐鲁制药) is a company that develops, manufactures, and markets generic drugs and active pharmaceutical ingredients (APIs).

View company
Intas Pharmaceuticals
HQ
Ahmedabad, IN
Employees
17,421↑ 1% increase

Intas is one of the leading global pharmaceutical formulation development, manufacturing, and marketing companies.

View company